Skip to content

Clinical trials

Phase 1 Lung Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Country / region: France Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20131
20151
20161
20174
20193
20213
20226
20244
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8
Completed7
Recruiting7
Terminated5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Eli Lilly and Company3
European Organisation for Research and Treatment of Cancer - EORTC2
Pfizer2
Amgen1
AstraZeneca1
Black Diamond Therapeutics, Inc.1
Blueprint Medicines Corporation1
Checkpoint Therapeutics, Inc.1
DeuterOncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms28
Carcinoma, Non-Small-Cell Lung18
Neoplasms12
Colorectal Neoplasms8
Breast Neoplasms7
Neoplasm Metastasis7
Colonic Neoplasms6
Endometrial Neoplasms6
Ovarian Neoplasms6
Stomach Neoplasms6

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.